NAPSA Antikörper
-
- Target Alle NAPSA Antikörper anzeigen
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NAPSA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human NAPSA
- Isotyp
- IgG
- Top Product
- Discover our top product NAPSA Primärantikörper
-
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 20-158) antibody
NAPSA Reaktivität: Human WB, ELISA, IHC Wirt: Maus Monoclonal 10C4B8 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal NAPSA-1238 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 25-250) antibodyNAPSA Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 64-420) antibodyNAPSA Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal NAPSA-3309 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC Wirt: Kaninchen Monoclonal MSVA-112R unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 368-397), (C-Term) antibodyNAPSA Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33879 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal rNAPSA-1239 unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Kaninchen Monoclonal NAPSA-1865R unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal NAPSA-1238-NAPSA-1239 unconjugated
-
- Applikationshinweise
- WB 1:500-1:2000, IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.6 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
- Andere Bezeichnung
- NAPSA (NAPSA Produkte)
- Synonyme
- KAP antikoerper, Kdap antikoerper, NAP1 antikoerper, NAPA antikoerper, SNAPA antikoerper, pronapsin antikoerper, kap antikoerper, kdap antikoerper, nap1 antikoerper, napa antikoerper, napsa antikoerper, snapa antikoerper, napsin A aspartic peptidase antikoerper, napsin A aspartic peptidase L homeolog antikoerper, NAPSA antikoerper, Napsa antikoerper, napsa.L antikoerper
- Hintergrund
- The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
- Molekulargewicht
- 45 kDa
- UniProt
- O96009
- Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
-
